These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 648644)

  • 1. Endometrial morphology of women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Luukkainen T; Arko H
    Fertil Steril; 1978 Apr; 29(4):397-401. PubMed ID: 648644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 24 mm levonorgestrel IUD on uterine endometrium of female rhesus monkeys, Macaca mulatta.
    Sethi N; Agarwal K; Singh RK; Bajpai VK
    Contraception; 1988 Jan; 37(1):99-108. PubMed ID: 3130222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
    Silverberg SG; Haukkamaa M; Arko H; Nilsson CG; Luukkainen T
    Int J Gynecol Pathol; 1986; 5(3):235-41. PubMed ID: 3093395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of a d-norgestrel-releasing IUD.
    Nilsson CG
    Contraception; 1977 Mar; 15(3):295-306. PubMed ID: 880809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A D-norgestrel-releasing IUD.
    Nilsson CG; Johansson ED; Luukkainen T
    Contraception; 1976 Apr; 13(4):503-14. PubMed ID: 1253602
    [No Abstract]   [Full Text] [Related]  

  • 7. D-norgestrel slow-releasing T device as an intrauterine contraceptive.
    El-Mahgoub
    Am J Obstet Gynecol; 1975 Sep; 123(2):133-8. PubMed ID: 1163576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD.
    Nilsson CG; Luukkainen T; Lähteenmäki P
    Contraception; 1978 Jun; 17(6):569-73. PubMed ID: 720062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of rhesus monkeys (Macaca mulatta) with intrauterine devices loaded with levonorgestrel.
    Wadsworth PF; Heywood R; Allen DG; Sortwell RJ; Walton RM
    Contraception; 1979 Aug; 20(2):177-84. PubMed ID: 114355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
    Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
    Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.
    Nilsson CG; Haukkamaa M; Vierola H; Luukkainen T
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):529-36. PubMed ID: 6819901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the progesterone-releasing intrauterine device on uterine endometrium and fallopian tube epithelium.
    Sheppard BL; Bonnar J
    Arch Toxicol Suppl; 1982; 5():231-4. PubMed ID: 6954905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
    Dallenbach-Hellweg G
    Int J Gynecol Pathol; 1988; 7(1):95-6. PubMed ID: 3127347
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device.
    Nilsson CG
    Contraception; 1977 Apr; 15(4):379-87. PubMed ID: 880815
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-releasing intrauterine device.
    Luukkainen T
    Ann N Y Acad Sci; 1991; 626():43-9. PubMed ID: 1905510
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
    Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial prostaglandin F content in women wearing nonmedicated or progestin-releasing intrauterine devices.
    Scommegna A; Ilekis J; Rao R; Dmowski WP; Rezai P; Auletta FJ
    Fertil Steril; 1978 May; 29(5):500-4. PubMed ID: 668929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained intrauterine release of d-norgestrel.
    Luukkainen T; Nilsson CG
    Contraception; 1978 Oct; 18(4):451-4. PubMed ID: 720077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.